MEDICLIN AG/ DE0006595101 /
2024-11-08 7:30:34 PM | Chg. -0.080 | Volume | Bid7:30:37 PM | Ask7:30:37 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
2.380EUR | -3.25% | 0 Turnover: 0.000 |
-Bid Size: - | -Ask Size: - | 116.85 mill.EUR | - | - |
Assets
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 194.6000 | 617.5000 | 572 | 508.3000 | 543.9380 | ||||||
Intangible Assets | 7.8000 | 8.9000 | 8.8000 | 7 | 5.6650 | ||||||
Long-Term Investments | .9000 | .9000 | .9000 | .8000 | - | ||||||
Fixed Assets | 296.2000 | 731.8000 | 683.6000 | 615.3000 | 654.1030 | ||||||
Inventories | 7.5000 | 8.1000 | 9.3000 | 8.5000 | 8.8690 | ||||||
Accounts Receivable | 93.1000 | 101.1000 | 76.3000 | 81.2000 | 88.4890 | ||||||
Cash and Cash Equivalents | 33.8000 | 37.2000 | 100.4000 | 119.5000 | 88.0390 | ||||||
Current Assets | 148.5000 | 166 | 203.9000 | 265.9000 | 262.0080 | ||||||
Total Assets | 444.7000 | 897.8000 | 887.5000 | 881.2000 | 916.1110 |
Liabilities
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 17.1000 | 17.6000 | 11.3000 | 13 | 14.4950 | ||||||
Long-term debt | 85.8000 | 472.2000 | 444.3000 | 397.6000 | 67.5420 | ||||||
Liabilities to Banks | 120.8000 | 564.8000 | 542.8000 | 514.7000 | - | ||||||
Provisions | 89.5000 | 99.6000 | 107.7000 | 98.6000 | 52.8330 | ||||||
Liabilities | 253.3000 | 707.1000 | 710.7000 | 698.2000 | 706.7890 | ||||||
Share Capital | 47.5000 | 47.5000 | 47.5000 | 47.5000 | - | ||||||
Total Equity | 191.4000 | 190.7000 | 176.8000 | 183 | 209.2060 | ||||||
Minority Interests | -.2000 | -.2000 | -.3000 | -.3000 | .1150 | ||||||
Total liabilities equity | 444.7000 | 897.8000 | 887.5000 | 881.2000 | 916.1110 |
Income Statement
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 645.1000 | 673.1000 | 659.9000 | 673.1000 | 704.6960 | ||||||
Depreciation (total) | 22.3000 | 71.2000 | 77.3000 | 73.7000 | 71.4040 | ||||||
Operating Result | 15.1000 | 22.4000 | .2000 | 11.6000 | 19.5190 | ||||||
Interest Income | -3.3000 | -10.8100 | -10.2500 | -9.2500 | -9.7430 | ||||||
Income Before Taxes | 11.9000 | 11.6000 | -10.1000 | 2.4000 | 9.7770 | ||||||
Income Taxes | 4.1000 | 1.9000 | -1.1000 | 1 | .0580 | ||||||
Minority Interests Profit | -.0500 | -.0200 | .0400 | -.0200 | .2780 | ||||||
Net Income | 7.7000 | 9.7000 | -9 | 1.5000 | 9.4400 |
Per Share
Cash Flow
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 29.7000 | 69.6000 | 118.7000 | 82 | 34.6390 | ||||||
Cash Flow from Investing Activities | -46.1000 | -35.6000 | -8.6000 | -7.1000 | -6.2420 | ||||||
Cash Flow from Financing | 23.4000 | -30.5000 | -46.5000 | -55.3000 | -56.1710 | ||||||
Decrease / Increase in Cash | 6.9000 | 3.4000 | 63.2000 | 19.6000 | - | ||||||
Employees | 7,726 | 7,323 | 7,349 | 7,115 | 7,025 |